Showing results (31-40 of 256) with videos related to
Sort By:
Pageof 26
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 1, 2012
[The hypofractionated radiotherapy in the treatment of the prostate cancer: radiate less to treat more]R Boissier, E GrossCurrent Opinion in Genetics & Development|September 5, 2001
Genetic control of skeletal developmentE F Wagner, G KarsentyBiochemical and Biophysical Research Communications|May 31, 1991
Conservation of binding sites for regulatory factors in the coordinately expressed alpha 1 (I) and alpha 2 (I) collagen promotersG Karsenty, B de CrombruggheThe Journal of Biological Chemistry|June 15, 1990
Two different negative and one positive regulatory factors interact with a short promoter segment of the alpha 1 (I) collagen geneG Karsenty, B de CrombruggheInternational Reviews of Immunology|January 1, 1995
Regulation of type I collagen genes expressionG Karsenty, R W ParkCurrent Opinion in Nephrology and Hypertension|August 5, 1998
New developments in bone formationM J Owen, G KarsentyJournal of Pediatric Urology|May 4, 2016
Postural therapy for renal stones in children: A Rolling Stones procedureA Faure, E Dicrocco, G Hery, et al.Science (New York, N.Y.)|September 1, 2000
The osteoblast: a sophisticated fibroblast under central surveillanceP Ducy, T Schinke, G KarsentyThe Journal of Biological Chemistry|December 29, 1995
A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting elementV Geoffroy, P Ducy, G KarsentyJournal De Pharmacologie|October 1, 1983
Postsynaptic striatal dopamine agonist or antagonist actions of (+) or (-) 3-PPP and modification after receptor deafferentationC Oberlander, J R BoissierPageof 26